The University of Palermo is a university located in Palermo, Italy, and founded in 1806. It is organized in 12 Faculties.

During the past decade, University of Palermo conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Palermo" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "University of Messina" with 2 trials sponsored and "University of Oxford" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Palermo" #1 collaborator was "University of Palermo" with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Linkoeping University" with 2 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "University of Palermo" are "Bladder Cancer" (3 trials), "Prostate Cancer" (3 trials), "Fibrosis, Liver" (2 trials), "Heart Failure" (2 trials) and "Metabolic Syndrome" (2 trials). Many other conditions were trialed in "University of Palermo" in a lesser frequency.

Most popular intervention types in "University of Palermo" are "Drug" (12 trials), "Procedure" (5 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials), "gemcitabine hydrochloride" (2 trials), "AL3818" (1 trials) and "AL3818 or placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Palermo" are 26 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Palermo". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in University of Palermo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Palermo, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

University of Palermo has several departments that took part in Clinical trials: "Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University" - 2 trials